Shasun Pharma announces completion of US FDA and Mexican COFEPRIS inspection

At its API facility at Cuddalore, Tamil Nadu

Shasun Pharmaceuticals announced that the Company has successfully completed the US FDA and Mexican COFEPRIS inspection at its API facility at Cuddalore, Tamil Nadu, India

Powered by Capital Market - Live News